HORIZON-EIC-2023-ACCELERATORCHALLENGES-01
HORIZON-EIC-2023-ACCELERATORCHALLENGES-01
Programme: Horizon Europe
4 projects · €9,987,762 total EU contribution (project-level) · 4 participating organizations · 4 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€9,987,762
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (1)
- Netherlands (1)
- NO (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- DoMore Diagnostics AS1 projects · NO
- HAWK BIOSYSTEMS1 projects · ES
- PAMGENE INT BV1 projects · NL
- Qlucore1 projects · SE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Precision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patients Histotype Px · 101161792 | HORIZON | €2,500,000 | €5,326,968 | Details |
canceR agnOstic immUnoTherapy predIctioN blood-tEst ROUTINE · 190109979 | HORIZON | €2,500,000 | €3,669,631 | Details |
IOO: a novel assay to predict patient response to immune checkpoint inhibitors, optimising patient stratification to these therapies and tripling solid tumour patient outcomes in immuno-oncology. IOO - Improving IO · 101161495 | HORIZON | €2,496,113 | €3,565,875 | Details |
The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancer QIandQD · 101161230 | HORIZON | €2,491,650 | €3,559,500 | Details |